Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Notes Payables (2019 - 2026)

Rockwell Medical filings provide 7 years of Notes Payables readings, the most recent being $264000.0 for Q4 2025.

  • On a quarterly basis, Notes Payables fell 1.49% to $264000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $264000.0, a 1.49% decrease, with the full-year FY2025 number at $264000.0, down 1.49% from a year prior.
  • Notes Payables hit $264000.0 in Q4 2025 for Rockwell Medical, down from $462000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.5 million in Q2 2022 to a low of $67000.0 in Q1 2025.
  • Median Notes Payables over the past 5 years was $488000.0 (2023), compared with a mean of $605333.3.
  • Biggest five-year swings in Notes Payables: rose 15.1% in 2022 and later plummeted 51.49% in 2023.
  • Rockwell Medical's Notes Payables stood at $437000.0 in 2021, then grew by 15.1% to $503000.0 in 2022, then plummeted by 51.49% to $244000.0 in 2023, then grew by 9.84% to $268000.0 in 2024, then fell by 1.49% to $264000.0 in 2025.
  • The last three reported values for Notes Payables were $264000.0 (Q4 2025), $462000.0 (Q3 2025), and $660000.0 (Q2 2025) per Business Quant data.